<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Deoliveira 2016&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Deoliveira 2016"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Deoliveira 2016</h1><p class="article date">2020-10-22</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/3315532 target=_blank>Sciwheel</a></p><p><a href=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117565/ target=_blank>Article</a><sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><h2 id=introduction>Introduction</h2><ul><li>Doxorubicin (DOX) presents dose dependent, cumulative and irreversible cardiotoxicity that can lead to cardiomyopathy and ultimately congestive heart failure, strongly associated to <strong>mitochondrial dysfunction</strong><ul><li>inhibit the electron transport chain (ETC) by binding to cardiolipin</li><li>redox cycling.</li><li>topoisomerase II poison and can form DNA adducts , which can damage the DNA and inhibit gene transcription and DNA replication</li></ul></li><li>can form vicious cycles -> chronic irreversible toxicity</li></ul><h2 id=method-and-results>Method and Results</h2><h3 id=the-model>The model</h3><p><img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g001&type=large" alt>
<img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g007&type=large" alt></p><ul><li>based on ETC-ROS and ME-R model with some modifications (please see suplement data)</li><li>TCA cycle, transporters, ROS production and scavenging systems and a detailed ETC representation</li><li>All simulations in this work consider that the mitochondria are in the presence of <strong>substrate and ADP (state 3</strong>)</li></ul><h4 id=etc-inhibition>ETC Inhibition</h4><ul><li>DOX binds onto cardiolipin in the IMM, IC50 values in the literature, with fitted Hill coefficients</li></ul><h4 id=redox-cycling>Redox Cycling</h4><ul><li>In the complex I, as a multiplier to IF site ROS generation.</li><li>7% increase in the superoxide concentration for 1mg/kg of DOX in rats (37mg/m2 in human, 5 to 30μM in mitochondria). <strong>7% increase for 30μM of DOX</strong> in this model.</li></ul><h4 id=damage-to-mtdna>Damage to mtDNA</h4><p><img src=https://user-images.githubusercontent.com/40054455/86617155-6d48e380-bfe9-11ea-8fa0-e721a26ae269.png alt=eqn1></p><ul><li>mass action model for mtDNA damage and repair. mtDNA level is normalized (scaled).</li><li>expression of all proteins and enzymes encoded in mtDNA was considered to be scaled by the mtDNA concentration</li><li>mtDNA damage by [•OH] (hydroxyl radical, derived from other ROS) and DOX directly</li></ul><h3 id=acute-effects>Acute Effects</h3><ul><li>constant concentration of the drug and performing a simulation until the model reached a steady state.
<img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g002&type=large" alt></li><li>For low drug concentrations, the ATP concentration and the membrane potential were only barely reduced</li><li>For high drug concentrations, mitochondrial function gradually deteriorate until a threshold is reached and the mitochondria completely collapse, with a complete loss of membrane potential and ATP concentration, a sharp increase in the ROS concentrations and a reduction in the O2 consumption to residual levels</li><li>Theshold: 210 μM
<img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g003&type=large" alt></li><li>dynamic simulations: fast absorbtion (5 mins) and slow elimination (24 hrs)</li><li>For low doses, mitochondrial function is only marginally affected, but at high doses, some significant variations can be observed. Mitochondrial function deteriorates as the dose increases</li><li>these effects are always temporary and all quantities return to their baseline values after the drug is fully eliminated from the system</li></ul><h3 id=chronic-effects>Chronic Effects</h3><p><img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g004&type=large" alt></p><ul><li>Added mtDNA model. stable region 0.75-0.73. unstable &lt; 0.73 (viscious cycle)
<img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g005&type=large" alt></li><li>weekly doses of 1mg/kg of DOX, 30μM in the model.</li><li>direct mtDNA damage by DOX is the main pathway that triggers this vicious cycle, being responsible for over 75% of the mtDNA content reduction during the acute stages of DOX intoxication.</li></ul><h3 id=cardioprotection-simulation>Cardioprotection Simulation</h3><p><img src="https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1005214.g006&type=large" alt></p><ul><li>Iron chelators to mitigate mtDNA damage and the loss of mtDNA content associated with DOX.</li><li>The simulations reproduced the setup of this in vivo experiment with rats</li><li>extending the chelating treatment to two of three times the duration of the DOX treatment might considerably increase the cardioprotection</li></ul><h2 id=discussion>Discussion</h2><ul><li>Redox cycling is the main contributor to acute increases in ROS concentrations at clinically relevant concentrations</li><li>ETC inhibition also showed negligible effects at clinically relevant concentrations, but more prominent @ lethal dose</li><li>redox cycling and ETC inhibition alone are not capable of generating any long term alterations in mitochondria function; mtDNA damage is necessary.</li><li>direct mtDNA damage by DOX is responsible for over 75% of the mtDNA content reduction during the acute stages of intoxication. ROS sustained the vicious cycle.</li><li>cardioprotective agent that has shown efficacy (partial protection)</li><li>extending the iron chelating therapy to time periods longer than the DOX treatment can enhance this protective property</li></ul><h3 id=limitations>Limitations</h3><ul><li>The repair systems of mtDNA are complex and still poorly understood</li><li>additional 15,000 simulations were performed, exhaustively exploring the space of potential parameter combinations</li><li>support the conclusion that direct damage to mtDNA by DOX is the main toxicity pathway responsible for triggering the vicious cycle</li><li>the expression of mtDNA encoded proteins was considered to be proportional to the mtDNA content<ul><li>there could be delays between the mtDNA damage and the reduction in the density of mtDNA encoded proteins</li></ul></li><li>do not take into account oxidative damage to any other structures or proteins</li></ul><h2 id=reference>Reference</h2><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>De Oliveira BL, Niederer S. A biophysical systems approach to identifying the pathways of acute and chronic doxorubicin mitochondrial cardiotoxicity. PLoS Comput. Biol. 2016;12(11):e1005214. doi:10.1371/journal.pcbi.1005214. <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/ellinwood-2017/><span class="iconfont icon-article"></span>Ellinwood 2017</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/demin-2001/><span class="iconfont icon-article"></span>Demin 2001</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>